In 1998, FIGO introduced a new staging system for endometrial cancer that is now surgical rather than clinical. The addition of extensive lymph node surgery, either formal lymphadenectomy or liberal sampling of the pelvic and aortic lymph nodes, represents the most significant and controversial component of this system. The yield of metastatic nodes is relatively low. The controversy surrounding this staging system are reviewed and some practical options considered.
Download full-text PDF |
Source |
---|
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!